SANUWAVE Health, Inc.
SANUWAVE Health, Inc. Fundamental Analysis
SANUWAVE Health, Inc. (SNWV) shows strong financial fundamentals with a PE ratio of 12.25, profit margin of 26.82%, and ROE of -1.42%. The company generates $0.0B in annual revenue with strong year-over-year growth of 59.99%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -99.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze SNWV's fundamental strength across five key dimensions:
Efficiency Score
ExcellentSNWV demonstrates superior asset utilization.
Valuation Score
ExcellentSNWV trades at attractive valuation levels.
Growth Score
ExcellentSNWV delivers strong and consistent growth momentum.
Financial Health Score
ModerateSNWV shows balanced financial health with some risks.
Profitability Score
ModerateSNWV maintains healthy but balanced margins.
Key Financial Metrics
Is SNWV Expensive or Cheap?
P/E Ratio
SNWV trades at 12.25 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, SNWV's PEG of 0.08 indicates potential undervaluation.
Price to Book
The market values SANUWAVE Health, Inc. at 89.39 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 21.55 times EBITDA. This signals the market has high growth expectations.
How Well Does SNWV Make Money?
Net Profit Margin
For every $100 in sales, SANUWAVE Health, Inc. keeps $26.82 as profit after all expenses.
Operating Margin
Core operations generate 11.23 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-1.42 in profit for every $100 of shareholder equity.
ROA
SANUWAVE Health, Inc. generates $31.63 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
SANUWAVE Health, Inc. generates limited operating cash flow of $3.89M, signaling weaker underlying cash strength.
Free Cash Flow
SANUWAVE Health, Inc. produces free cash flow of $3.89M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.45 in free cash annually.
FCF Yield
SNWV converts 2.67% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
12.25
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.08
vs 25 benchmark
P/B Ratio
Price to book value ratio
89.39
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.30
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
14.19
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.38
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-1.42
vs 25 benchmark
ROA
Return on assets percentage
0.32
vs 25 benchmark
ROCE
Return on capital employed
0.25
vs 25 benchmark
How SNWV Stacks Against Its Sector Peers
| Metric | SNWV Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 12.25 | 28.45 | Better (Cheaper) |
| ROE | -141.56% | 763.00% | Weak |
| Net Margin | 26.82% | -45265.00% (disorted) | Strong |
| Debt/Equity | 14.19 | 0.34 | Weak (High Leverage) |
| Current Ratio | 1.38 | 2795.60 | Neutral |
| ROA | 31.63% | -16588.00% (disorted) | Strong |
SNWV outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews SANUWAVE Health, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
144612.42%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
-13621.50%
Industry Style: Defensive, Growth, Innovation
DecliningFCF CAGR
1846.94%
Industry Style: Defensive, Growth, Innovation
High Growth